Seeing Is Believing
Healthcare - Sector
GlaxoSmithKline PLC ADR's activity chart (see below) currently has 12 price targets and 12 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.14% with an average time for these price targets to be met of 416.12 days.
Most recent stock forecast was given by JAMES GORDON from BARCLAYS on 06-Jan-2026. First documented stock forecast 28-Jul-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Jan-2026
6 months 24 days ago
(06-Jan-2026)
0/14 (0%)
$-14.94 (-44.95%)
Hold Since 06-Feb-2025
1 years 5 months 24 days ago
(06-Feb-2025)
0/8 (0%)
$-13.03 (-35.61%)
Buy Since 08-Nov-2023
$41
$-11.5 (-21.90%)
$20.29
1 years 7 months 28 days ago
(02-Dec-2024)
1/2 (50%)
$8.37 (25.65%)
192
Buy Since 10-Feb-2024
1 years 8 months 18 days ago
(12-Nov-2024)
5/5 (100%)
$17.4 (48.88%)
345
Hold Since 10-Nov-2021
1 years 8 months 22 days ago
(08-Nov-2024)
0/6 (0%)
$-14.45 (-42.70%)
What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on GSK (GlaxoSmithKline PLC ADR) with a proven track record?
Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?
Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?
Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?